Literature DB >> 610052

The metabolic fate of prazosin.

J A Taylor, T M Twomey, M S von Wittenau.   

Abstract

1. [2-14C]Prazosin is rapidly distributed into tissues of the dog including heart, lung and vascular tissues. 2. Urinary excretion by rats and dogs is low, biliary secretion being the major route of elimination. 3. Biotransformation of prazosin in the rat and dog occurs primarily by 6- or 7-O-dealkylation and subsequent glucuronide formation, and to a lesser extent via N-dealkylation. 4. Preliminary metabolic studies in man indicate a pattern of metabolites similar to that observed in dogs and rats.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 610052     DOI: 10.3109/00498257709035794

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  19 in total

1.  Comparative bioavailability study of two brands of prazosin-containing tablets in healthy volunteers.

Authors:  P J Guelen; T J Janssen; M H Lam; T B Vree; P S Exler
Journal:  Pharm Weekbl Sci       Date:  1990-10-19

2.  Lack of relationship between debrisoquine oxidation phenotype and the pharmacokinetics and first dose effect of prazosin.

Authors:  M S Lennard; J C McGourty; J H Silas
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

3.  Studies on the clinical pharmacology of prazosin. I: Cardiovascular, catecholamine and endocrine changes following a single dose.

Authors:  P C Rubin; T F Blaschke
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

4.  Time-dependent effects of prazosin on the development of methamphetamine conditioned hyperactivity and context-specific sensitization in mice.

Authors:  André O White; Anthony S Rauhut
Journal:  Behav Brain Res       Date:  2014-01-31       Impact factor: 3.332

5.  Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain.

Authors:  D B Menkes; J M Baraban; G K Aghajanian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

6.  3H-WB 4101 binding in the rat vas deferens. Effects of chronic treatments with desipramine and prazosin.

Authors:  H W Wetzel; M S Briley; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

7.  Prazosin, pharmacokinetics and concentration effect.

Authors:  D N Bateman; D C Hobbs; T M Twomey; E A Stevens; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

8.  Prazosin disposition in young and elderly subjects.

Authors:  P C Rubin; P J Scott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

9.  The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

Authors:  B Kaye; N J Cussans; J K Faulkner; D A Stopher; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

10.  The effect of long-term administration of alpha 1-blocker prazosin on capillary density in cardiac and skeletal muscle.

Authors:  A Ziada; O Hudlicka; K R Tyler
Journal:  Pflugers Arch       Date:  1989-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.